Individual Study / WHS

Women's Health Study

Women's Health Study

WHS logo
Initiatives -
To test the benefits and risks of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer. **General contact: whs@partners.org**
Start Year
1993
End Year
2019
Funding
Trial (1991-2994): funded jointly by the National Cancer Institute (NCI) and the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). Observational follow-up (2004 - ongoing): NCI
Visit WHS

Members

Download
Investigators Contacts
  • MD. Dr I-Min Lee
    Harvard T.H. Chan School of Public Health

Design

Study design
Clinical trial cohort
Follow Up
At the end of the trial (2004), participants were invited to be followed observationally, by completing yearly endpoint and risk factor questionnaires, to evaluate cancer and CVD hypotheses.

Marker Paper

Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med. 2000 Jan-Feb;9(1):19-27. doi: 10.1089/152460900318911.

PUBMED 10718501

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
39,876
Number of participants with biosamples
Supplementary Information
Health professionals. Women.

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

By contacting the study representative